Clinical Trials in Egypt / NCT07491965
Recruiting
Observational
Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency .
NCT07491965 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Benign Paroxysmal Positional Vertigo (BPPV)
Investigational drug(s) / intervention(s)
Vitamin D
Vitamin D: Level of Vitamin D
Study summary
Association between Benign Paroxysmal Positional Vertigo and Vitamin D deficiency
Eligibility
Inclusion Criteria:
* • Cases: Adults with a confirmed diagnosis of idiopathic BPPV based on positive Dix-Hallpike maneuver (nystagmus and vertigo lasting \<1 minute).
* Controls: Adults attending ENT clinic without history of vertigo or BPPV, confirmed by negative Dix-Hallpike test.
Exclusion Criteria:
* Known causes of secondary vertigo (e.g., Meniere's disease, vestibular neuritis, central vertigo).
* Conditions affecting vitamin D metabolism (e.g., chronic kidney disease, malabsorption syndromes, hyperparathyroidism).
* Use of medications interfering with vitamin D levels (e.g., anticonvulsants, glucocorticoids) in the past 3 months.
* Pregnancy or lactation.
* Inability to provide consent.
Primary outcome measure(s)
- Level of Vitamin D in patients with Benign Paroxysmal Positional Vertigo — From enrollment to 1 months after investigation
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sohag University Hospital | Sohag | Egypt | Recruiting |
More Sohag University trials in Egypt
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07491965 on ClinicalTrials.gov ↗ ← All trials in Egypt